FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation

H. Zhou, Y. Liu*, R. Zhu, F. DIng, Y. Wan, Y. Li, Z. Liu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint Dive into the research topics of 'FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation'. Together they form a unique fingerprint.

Medicine & Life Sciences